Lipids and Lipid Derivatives
Medchemexpress LLC RU 24969 succinate | 107008-28-6 | 99.6% | 346.38 | 50 MG
RU 24969 succinate is a 5-HT receptor agonist with Ki values of 0.38 and 2.5 nM for 5-HT1B and 5-HT1A, respectively. This compound decreases fluid consumption and increases forward locomotion, making it suitable for research into neurological diseases.
- Acts as a 5-HT receptor agonist with Ki values of 0.38 nM for 5-HT1B and 2.5 nM for 5-HT1A.
- Decreases fluid consumption and increases forward locomotion.
- Can be used for the research of neurological disease.
- Dose-dependently inhibits K+ evoked efflux of tritium (30 nM-1 μM) with a pD2 value of 7.45 for the maximum effect at 1 μM.
- Potentiates addictive agent-induced effects (1 and 3 mg/kg; s.c., once) and dose-dependently decreases water consumption in water deprived rats (0.03-3.0 mg/kg; s.c., once).
eMolecules Chem-Impex Lauric acid 1kg 603112293 34486 0 000 143-07-7 MFCD00002736 200 322 C12H24O2
Chem-Impex Lauric acid 1kg 603112293 34486 0 000 143-07-7 MFCD00002736 200 322 C12H24O2
Medchemexpress LLC Lithium stearate 50g
Lithium stearate (Stearic acid (lithium)) is a compound that forms vesicles in reaction with silver nitrate thereby changing the reaction kinetics of the nucleation and self-assembly process of silver stearate It has the activity that even in the presence of excess silver nitrate only about 80% can be converted into silver stearate and the residual lithium stearate will inhibit the growth process of silver stearate crystals thereby producing silver stearate crystals that are much smaller than those obtained from sodium stearate providing an opportunity to further control the self-assembly and crystal growth of silver stearate